Similar articles

• Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.

  van den Berg MP, Verhoef JC, Romeijn SG, Merkus FW. van den Berg MP, et al. Eur J Pharm Biopharm. 2004 Jul;58(1):131-5. doi: 10.1016/j.ejpb.2004.02.010. Eur J Pharm Biopharm. 2004. PMID: 15207546
• [Therapy of functional uterine hemorrhages with intravenous progesterone].

  LEEB H. LEEB H. Geburtshilfe Frauenheilkd. 1953 Apr;13(4):322-6. Geburtshilfe Frauenheilkd. 1953. PMID: 13068560 Undetermined Language. No abstract available.
• Use of intramuscular progesterone versus intravenous albumin for the prevention of ovarian hyperstimulation syndrome.

  Costabile L, Unfer V, Manna C, Gerli S, Rossetti D, Di Renzo GC. Costabile L, et al. Gynecol Obstet Invest. 2000;50(3):182-5. doi: 10.1159/000010306. Gynecol Obstet Invest. 2000. PMID: 11014951 Clinical Trial.
• Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.

  Scavone C, Bonagura AC, Fiorentino S, Cimmaruta D, Cenami R, Torella M, Fossati T, Rossi F. Scavone C, et al. Drugs R D. 2016 Jun;16(2):129-40. doi: 10.1007/s40268-016-0123-2. Drugs R D. 2016. PMID: 26939533 Free PMC article. Review.
• Progesterone: review of safety for clinical studies.

  Goletiani NV, Keith DR, Gorsky SJ. Goletiani NV, et al. Exp Clin Psychopharmacol. 2007 Oct;15(5):427-44. doi: 10.1037/1064-1297.15.5.427. Exp Clin Psychopharmacol. 2007. PMID: 17924777 Review.